Literature DB >> 7037105

Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices.

M S Barsoum, F I Bolous, A A El-Rooby, M A Rizk-Allah, A S Ibrahim.   

Abstract

One hundred patients with bleeding oesophageal varices were randomized into two treatment groups after resuscitation. One group was managed by tamponade only (group 1); the other group (group 2) was treated by endoscopic injection of oesophageal varices. The patients in group 2 were further subdivided into 25 patients (group 2a), who had tamponade applied immediately after sclerotherapy, and 25 patients (group 2b), who had sclerotherapy without subsequent tamponade. Injection of varices controlled the acute bleeding episode more effectively than tamponade (74 per cent in group 2 v. 42 per cent in group 1). There was no significant difference in the overall mortality rate of the two groups, but group 2 had a significantly higher proportion of Child's grade C patients (38/50 v. 29/50 = 76 v. 58 per cent). If only Child's grade C patients are considered, 16 out of 29 (55 per cent) died in group 1, whereas only 12 out of 38 (32 per cent) died in group 2 (P less than 0.05). Tamponade applied after sclerotherapy had no demonstrable effect on the outcome of sclerotherapy. The long term follow-up of patients (maximum 4 years) showed that recurrence of bleeding was less in the sclerotherapy group (8.1 per cent) than in the tamponade only group (27.6 per cent; P less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7037105     DOI: 10.1002/bjs.1800690206

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  31 in total

1.  UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology.

Authors:  R Jalan; P C Hayes
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  Effects of endoscopic variceal sclerotherapy using GT XIII on blood coagulation tests and the renal kallikrein-kinin system.

Authors:  N Yuki; M Kubo; Y Noro; N Hayashi; H Fusamoto; A Ito; M Masuzawa; T Kamada
Journal:  Gastroenterol Jpn       Date:  1990-10

Review 3.  Portal hypertension--25 years of progress.

Authors:  B R MacDougall; D Westaby; L A Blendis
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 4.  The use of sclerotherapy for the management of oesophageal varices in portal hypertension.

Authors:  J Terblanche
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

5.  Immediate endoscopic sclerosis of bleeding esophageal varices. A prospective evaluation over five years.

Authors:  K J Paquet; J F Kalk; P Koussouris
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

6.  Emergency and elective sclerotherapy of oesophageal varices.

Authors:  A B Szczepanik; W J Rudowski
Journal:  Ann R Coll Surg Engl       Date:  1988-01       Impact factor: 1.891

7.  Distal splenorenal shunt for management of variceal bleeding in patients with schistosomal hepatic fibrosis.

Authors:  F A Ezzat; K M Abu-Elmagd; I Y Aly; M A Aly; O M Fathy; M H el-Barbary; O O Bahgat; A A Salam; M H Kutner
Journal:  Ann Surg       Date:  1986-11       Impact factor: 12.969

Review 8.  Sclerotherapy for bleeding esophageal varices after randomized trials.

Authors:  D A Lieberman
Journal:  West J Med       Date:  1986-10

9.  Combined (short-term plus longterm) sclerotherapy v short-term only sclerotherapy: a randomised prospective trial.

Authors:  M Moretó; M Zaballa; E Ojembarrena; S Ibáñez; M J Suárez; F Setién; E Delgado
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

Review 10.  Acute management of bleeding oesophageal varices.

Authors:  A K Burroughs
Journal:  Drugs       Date:  1992       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.